141 related articles for article (PubMed ID: 22726382)
21. [Treatment has a positive impact on the long-term evolution of chronic hepatitis B].
Marcellin P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S99-102. PubMed ID: 21095519
[No Abstract] [Full Text] [Related]
22. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
23. Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.
Marcellin P; Arama V; Leblebicioglu H; Zarski JP; Zeuzem S; Mauss S; Sieklucki J; Acalovschi M; Usluer G; Klauck I; Morais E; Bjork S; Lescrauwaet B; Kamar D; Simon K;
Antivir Ther; 2014; 19(3):235-43. PubMed ID: 23574686
[TBL] [Abstract][Full Text] [Related]
24. On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future.
Liaw YF
Antivir Ther; 2009; 14(1):13-22. PubMed ID: 19320233
[TBL] [Abstract][Full Text] [Related]
25. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
Yue W; Yuan H; Mao XR; Deng YD; Chen L
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
[TBL] [Abstract][Full Text] [Related]
26. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Janssen HL; Sonneveld MJ; Brunetto MR
Gut; 2012 May; 61(5):641-5. PubMed ID: 22180061
[No Abstract] [Full Text] [Related]
27. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
[TBL] [Abstract][Full Text] [Related]
28. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
29. Treatment of chronic hepatitis B in HIV-infected patients in 2007.
Garcia-Gasco P; Sheldon J; Soriano V
J HIV Ther; 2007 Mar; 12(1):19-23. PubMed ID: 17589392
[No Abstract] [Full Text] [Related]
30. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
[TBL] [Abstract][Full Text] [Related]
31. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
[TBL] [Abstract][Full Text] [Related]
32. Improving outcomes for patients with chronic hepatitis B.
Gish RG
Curr Gastroenterol Rep; 2007 Mar; 9(1):14-22. PubMed ID: 17335673
[TBL] [Abstract][Full Text] [Related]
33. [Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Pais R; Benhamou Y
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S136-41. PubMed ID: 21095517
[TBL] [Abstract][Full Text] [Related]
34. Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
You H; Wu X; Ou X; Ma H; Wang Q; Liu T; Cong M; Wang P; Wang B; Jia J
Antivir Ther; 2011; 16(3):299-307. PubMed ID: 21555812
[TBL] [Abstract][Full Text] [Related]
35. The maze of treatments for hepatitis B.
Lok AS
N Engl J Med; 2005 Jun; 352(26):2743-6. PubMed ID: 15987924
[No Abstract] [Full Text] [Related]
36. Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.
Cao ZH; Ma LN; Zhang HW; Liu YL; Chen XY
J Dig Dis; 2013 Aug; 14(8):446-50. PubMed ID: 23615131
[TBL] [Abstract][Full Text] [Related]
37. [Therapy of hepatitis B virus infection].
Trautwein C
Praxis (Bern 1994); 2006 Sep; 95(36):1389-97. PubMed ID: 16989182
[TBL] [Abstract][Full Text] [Related]
38. [Chronic hepatitis B: current therapy].
Buffet C
Bull Acad Natl Med; 2008 Nov; 192(8):1625-37; discussion 1638-9. PubMed ID: 19445377
[TBL] [Abstract][Full Text] [Related]
39. Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.
Papatheodoridis GV
Liver Int; 2011 Jan; 31 Suppl 1():95-103. PubMed ID: 21205145
[TBL] [Abstract][Full Text] [Related]
40. [Protocol for the antiviral therapy of hepatitis B and D].
; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
